E
0913693 B.C. Ltd. RP.V
TSX
Recommendation
Sell
Prev Close
$0.015
Volume
--
Avg Vol (90D)
18,768
Market Cap
$140.01K
Dividend & Yield
--
52-Week Range
$0.01 - $0.05
P/E (TTM)
--
EPS (TTM)
-$0.0016
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Weak
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
K1 to Exit Irwin, a Leading Investor Relations Platform, in Strategic Sale to FactSet
10/29/2024 - PR Newswire
K1 to Exit Axcient, a Category Leader in Business Continuity and Disaster Recovery Solutions
9/11/2024 - PR Newswire
K1 Acquires MariaDB, a Leading Database Software Company, and Appoints New CEO
9/10/2024 - PR Newswire
K1 Announces Strategic Growth Investment in AI-Powered Board Management Software Platform, Board Intelligence
8/6/2024 - PR Newswire
K1 Completes Strategic Exit of GoCanvas to Nemetschek Group
7/3/2024 - PR Newswire
Income Statement
Total Revenue (TTM)
$258.20K
EBITDA (TTM)
-$262.80K
EBIT (TTM)
-$263.20K
Net Income (TTM)
-$78.50K
Balance Sheet
Total Assets (Q)
$102.20K
Total Debt (Q)
$473.70K
Total Liabilities (Q)
$3.24M
Book Value Per Share (Q)
-$0.0426
Cash Flow
Cash from Operations (TTM)
-$388.10K
Cash from Investing (TTM)
$12.80K
Cash from Financing (TTM)
$333.00K
Net Change in Cash (TTM)
-$42.20K
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
0.63
7-Day Total Return
0.00%
30-Day Total Return
50.00%
60-Day Total Return
-25.00%
90-Day Total Return
50.00%
Year to Date Total Return
-50.00%
1-Year Total Return
-72.73%
2-Year Total Return
-90.32%
3-Year Total Return
-90.91%
5-Year Total Return
-94.44%
52-week Low
Oct 31, 2024 - $0.01
52-week High
Oct 22, 2024 - $0.05
Valuation
Market Cap
$140.01K - Nano Cap
Enterprise Value
$612.46K
Price/Sales (TTM)
3.85
Price/Book (Q)
-0.35
Dividends and Shares
Shares Outstanding
64.71M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.replicel.com
Phone Number
604 248 8730
Address
570 Granville Street
Vancouver, BC V6C 3P1
Country
Canada
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
0913693 B.C. Ltd., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy to treat... more
Weiss Ratings